utilizing macular ganglion cell inner plexiform layer thickness to predict visual outcomes in chiasmal compression) [6], enhancements in surgical management [i.e
doi:10.1016/j.peptides.2005.01.023
Six participants were excluded due to spectral quality issues, leaving 76 participants for analysis: 20 healthy controls (HC), 19 TTH patients, and 37 migraine patients (27 without aura, 10 with aura)
Honestly, I feel like we're sitting at only the beginning of a potential game-changing pharmacological breakthrough for obesity treatment.
In the same timeframe I also started collecting data, so getting my book ready
AI at the J.P Morgan Healthcare Conference: Practical Advances in Health Tech, Challenges in Drug Discovery Last year, while AI continued to make waves in health techparticularly in clinical decision support toolshigh implementation costs challenged broader adoption